Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $282,238 (100.0% shares, 0.0% debt)

Holdings (18)

— MERUS N V 31.8%

Value ($000) $89,622 Shares 1,793,866 Est. Cost $36.34 Unrealized —

STOK STOKE THERAPEUTICS INC 22.6%

Value ($000) $63,751 Shares 5,187,191 Est. Cost $7.94 Unrealized +78.5%

CCCC C4 THERAPEUTICS INC 13.9%

Value ($000) $39,219 Shares 6,880,527 Est. Cost $4.53 Unrealized +32.9%

GHRS GH RESEARCH PLC 9.9%

Value ($000) $28,071 Shares 4,195,894 Est. Cost $9.20 Unrealized +11.5%

TCRX TSCAN THERAPEUTICS INC 9.2%

Value ($000) $26,019 Shares 5,224,600 Est. Cost $2.68 Unrealized +125.2%

ALLO ALLOGENE THERAPEUTICS INC 6.2%

Value ($000) $17,367 Shares 6,202,374 Est. Cost $2.77 Unrealized -3.7%

CGEM CULLINAN THERAPEUTICS INC 2.4%

Value ($000) $6,877 Shares 410,830 Est. Cost $21.00 Unrealized -15.5%

— PASSAGE BIO INC 2.1%

Value ($000) $5,899 Shares 8,426,955 Est. Cost $1.07 Unrealized —

IBIO IBIO INC 0.7%

Value ($000) $1,914 Shares 862,279 Est. Cost $1.77 Unrealized +11.3%

CRBU CARIBOU BIOSCIENCES INC 0.5%

Value ($000) $1,333 Shares 680,189 Est. Cost $2.05 Unrealized 0.0%

KOD KODIAK SCIENCES INC 0.3%

Value ($000) $708 Shares 271,177 Est. Cost $2.66 Unrealized 0.0%

— PIERIS PHARMACEUTICALS INC 0.2%

Value ($000) $621 Shares 37,436 Est. Cost $9.81 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 0.1%

Value ($000) $278 Shares 17,400 Est. Cost $11.30 Unrealized —

— BIONOMICS LIMITED 0.1%

Value ($000) $241 Shares 549,673 Est. Cost $2.69 Unrealized —

KNSA KINIKSA PHARMACEUTICALS INTL 0.1%

Value ($000) $206 Shares 8,231 Est. Cost $18.73 Unrealized +30.0%

TENX TENAX THERAPEUTICS INC 0.0%

Value ($000) $51 Shares 14,751 Est. Cost $3.62 Unrealized 0.0%

IPSC CENTURY THERAPEUTICS INC 0.0%

Value ($000) $33 Shares 19,028 Est. Cost $1.96 Unrealized 0.0%

VYNE VYNE THERAPEUTICS INC 0.0%

Value ($000) $30 Shares 16,194 Est. Cost $2.49 Unrealized -24.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	1,793,866	$89,622	31.8%	$36.34	—	COM	N5749R100
STOK	STOKE THERAPEUTICS INC	5,187,191	$63,751	22.6%	$7.94	+78.5%	COM	86150R107
CCCC	C4 THERAPEUTICS INC	6,880,527	$39,219	13.9%	$4.53	+32.9%	COM STK	12529R107
GHRS	GH RESEARCH PLC	4,195,894	$28,071	9.9%	$9.20	+11.5%	ORDINARY SHARES	G3855L106
TCRX	TSCAN THERAPEUTICS INC	5,224,600	$26,019	9.2%	$2.68	+125.2%	COM	89854M101
ALLO	ALLOGENE THERAPEUTICS INC	6,202,374	$17,367	6.2%	$2.77	-3.7%	COM	019770106
CGEM	CULLINAN THERAPEUTICS INC	410,830	$6,877	2.4%	$21.00	-15.5%	COM	230031106
—	PASSAGE BIO INC	8,426,955	$5,899	2.1%	$1.07	—	COM	702712100
IBIO	IBIO INC	862,279	$1,914	0.7%	$1.77	+11.3%	CON NEW	451033708
CRBU	CARIBOU BIOSCIENCES INC	680,189	$1,333	0.5%	$2.05	0.0%	COM	142038108
KOD	KODIAK SCIENCES INC	271,177	$708	0.3%	$2.66	0.0%	COM	50015M109
—	PIERIS PHARMACEUTICALS INC	37,436	$621	0.2%	$9.81	—	COM NEW	720795202
CNTA	CENTESSA PHARMACEUTICALS PLC	17,400	$278	0.1%	$11.30	—	SPONSORED ADS	152309100
—	BIONOMICS LIMITED	549,673	$241	0.1%	$2.69	—	ADS	09063M205
KNSA	KINIKSA PHARMACEUTICALS INTL	8,231	$206	0.1%	$18.73	+30.0%	ORD SHS CL A	G52694109
TENX	TENAX THERAPEUTICS INC	14,751	$51	0.0%	$3.62	0.0%	COM NEW	88032L605
IPSC	CENTURY THERAPEUTICS INC	19,028	$33	0.0%	$1.96	0.0%	COM	15673T100
VYNE	VYNE THERAPEUTICS INC	16,194	$30	0.0%	$2.49	-24.0%	COM	92941V308